Life Science Builders
No Patient Left Behind’s work unites stakeholders across the biotech ecosystem.
Life Science Builders support our mission to protect the development of future cures, guarantee universal access to new medicines through insurance reform, and ensure old drugs become generic as intended by the patent-system.
Burt Adelman MD
Paul Bolno MD
Kevin Buchi
Ron Cohen MD
Riley Ennis
Ramin Farzaneh-Far MD
Michael Gilman PhD
Kurt Graves
Mike Grey
Christian Henry
Rahul Kakkar MD
Laurie Keating
Peter Lanciano
Steve Lufkin
Keith Murphy
Gabriel Otte
Ken Rhodes PhD
Vicki Sato PhD
Steve Sherwin MD
Peter Thompson MD
Ypke Van Oosterhout PhD
Frank Watanabe
Peter Wirth
Innovators
Rahul Ballal PhD
Axel Bolte
Pablo Cagnoni MD
Mark Corrigan MD
David Epstein
Cedric Francois MD PhD
Jeffrey Goldberg
Barry Greene
David-Alexandre Gros MD
Stephen Hoffman MD PhD
Matthew Kane
Rachel King
Andrew Levin MD PhD
Greg Mann
Michael Narachi
Michael Panzara MD
Wendye Robbins MD
Pratik Shah PhD
Tim Springer PhD
Nancy Thornberry MD
Chandra Vargeese PhD
Greg Weaver
Daphne Zohar
Glenn Batchelder
Eamon Brady
Bharatt Chowrira PhD
Milind Deshpande PhD
Doug Fambrough PhD
Patricia Fraser MD
Robert Gould PhD
Yvonne Greenstreet MBChB
Paul Hastings
Troy Ignelzi
Perry Karsen
Rick Klausner MD
Jeremy Levin DPhil MB CHB
John Maraganore PhD
Bill Newell
Scott Rakestraw PhD
Adam Rosenberg
Laura Shawver PhD
Ken Takanashi
John Tucker
Mark Velleca MD PhD
Michael Weiss
Gil Beyen
Aoife Brennan MB CHB
Gustav Christensen
Michael Ehlers MD PhD,
Marsha Fanucci
Ilan Ganot
Dan Grau
Jim Greenwood
Michael Hayden MD PhD
Jose Juves
David Katz PhD
John Kollins
Ted Love MD
Marcos Milla PhD
Tim Noyes
Adrian Rawcliffe
Gino Santini
Vikram Sheel Kumar MD
Ruth Thieroff-Ekerdt MD
Dave Van Meter
Gregory Verdine PhD
Wendell Wierenga PhD
Andy Acker
Janus Henderson Investors
Pieter Boelhouwer
RA Capital Management
Aaron Davis
Boxer Capital
Jean-Francois Formela MD
Atlas Venture
Corey Goodman PhD
venBio Partners
Rob Hopfner PhD
Pivotal Life Sciences
Peter Kolchinsky PhD
RA Capital Management
Dan Lyons PhD
Janus Henderson Investors
Jack Nielsen
Vivo Capital
Josh Resnick MD
RA Capital Management
Rajeev Shah
RA Capital Management
Otello Stampacchia PhD
Omega Funds
Graham Walmsley MD PhD
Logos Global Management
Investors
Gaurav Aggarwal MD
Gaurav Enterprises
Bruce Booth DPhil
Atlas Venture
Bob Deresiewicz MD
Wellington Management Company
Howie Furst MD
Deerfield Management
Arjun Goyal MD
VIDA Ventures
Wende Hutton
Canaan
Jonathan Leff
Sofinnova
Adam Mikkelson
Camber Capital Management
Art Pappas
Pappas Capital
Thilo Schroeder PhD
Nextech
Tim Shannon MD
Canaan
Clay Thorp
Hatteras Venture Partners
Christoph Westphal MD PhD
Longwood Fund
Rich Aldrich
Longwood Fund
Janice Bourque
Hercules Technology Growth Capital
Michelle Dipp MD PhD
Biospring Partners
Scott Gazelle MD PhD
GreyBird Ventures
Walter H. Moos PhD
Pandect Bioventures
Alex Karnal
Braidwell
Jay Lichter PhD
Avalon Ventures
Janis Naeve PhD
Cota Capital
Rob Perez
General Atlantic
Andy Schwab
5AM Ventures
David Socks
Mountainfield Venture Partners
Jamie Topper MD
Frazier Life Sciences
Andreas Wicki PhD
HBM Healthcare Investors
David Beier
Bay City Capital
Brook Byers
Kleiner Perkins
Jon Edwards PhD
Biotech VC
David Goeddel PhD
The Column Group
Martin Heidecker PhD
AMR Action Fund
Nina Kjellson
Canaan
Jakob Loven PhD
Nextech
Sara Nayeem MD
Enavate Sciences
Matthew Perry
BVF Partners
Nimish Shah
Venrock
Steve Squinto PhD
JP Morgan Asset Management
DA Wallach
Time BioVentures
Catherine Arnold
Centerview Partners
Jeffrey Solomon
TD Cowen
Industry Advisors
Bruce Dobbs
Singh Biotechnology
Rick Wiessenstein
TD Cowen
Julia Gaebler PhD
Cytel
Jonathan Kfoury
Bay Area Global Health Alliance
We’re building support across the biotech ecosystem
BECOME A FIRST RESPONDER & THOUGHT PARTNER
Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.